Buy or sell XinThera stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

XinThera Stock
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
About XinThera Stock
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Funding History
August 2021 | $50.0M |
---|
Management
Board Member
Carl L. Gordon
Co-founder and Senior Vice President
Gene Hung
Board Member
Michael Rome
Co-Founder and Chairman
Stephen Kaldor
Board Member
Jim Tananbaum
President & CSO
Qing Dong
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase